Episode
Psychedelics for the Menopause Transition with Alicia Bigelow, ND
- Published
- Dec 17, 2025
- Duration seconds
- 2126
- Processing state
not_requested- Canonical source
- https://plantmedicinepodcast.libsyn.com/psychedelics-for-the-menopause-transition-with-alicia-bigelow-nd
Actions
POST https://stenobird.com/v1/public/podcasts/psychedelic-medicine-podcast-with-dr-lynn-marie-morski-835820/episodes/psychedelics-for-the-menopause-transition-with-alicia-bigelow-nd/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/psychedelic-medicine-podcast-with-dr-lynn-marie-morski-835820/psychedelics-for-the-menopause-transition-with-alicia-bigelow-nd.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
In this episode, Alicia Bigelow, ND joins to discuss the potential of psychedelic medicine to support the menopause transition. Dr. Ali Bigelow is a naturopathic physician, ketamine provider and licensed psilocybin facilitator in Portland, OR. She leads individual and group retreats, enjoys incorporating live music into her sessions when desired, and is passionate about supporting those navigating life transitions, such as end of life and menopause, through her low dose group, Menomorphosis. Dr. Bigelow will be doing retreats in 2026 with Rise Up Journeys at RiseUpJourneys.com In this conversation, Dr. Bigelow explores the emerging intersection between psychedelics and the menopausal transition, framing perimenopause and menopause as profound neuroendocrine, psychological, and existential shifts rather than merely clinical syndromes. She also discusses how hormonal changes—particularly declining estrogen—interact with serotonin, inflammation, and neuroplasticity, potentially shaping psychedelic experiences and outcomes. Throughout the discussion, Dr. Bigelow emphasizes the unique capacity of psychedelics to support self-actualization, identity reformation, and meaning-making during midlife, especially when combined with hormone therapy, intentional integration practices, and strong community support. In this episode, you'll hear: Why perimenopause and menopause represent a major but under-recognized neurobiological life transition How estrogen, serotonin receptors, and psychedelics like psilocybin may interact in midlife What we know (and don't yet know) about hormone replacement therapy and psychedelic efficacy The potential anti-inflammatory effects of psychedelics and their relevance to menopausal symptoms How ketamine may function differently from classic psychedel…